Subtype of SCLC Is an Intrinsic and Persistent Feature Through Systemic Treatment

INTRODUCTION: SCLC is an aggressive malignancy with poor outcome. Most patients have disease recurrence despite treatments with multiple modalities. Subtyping of SCLC has been proposed recently, and novel agents targeting specific subtypes are actively being investigated. In this study, we evaluated...

Descripción completa

Detalles Bibliográficos
Autores principales: Lo, Ying-Chun, Rivera-Concepcion, Joel, Vasmatzis, George, Aubry, Marie-Christine, Leventakos, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507151/
https://www.ncbi.nlm.nih.gov/pubmed/37731627
http://dx.doi.org/10.1016/j.jtocrr.2023.100561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507151/
https://www.ncbi.nlm.nih.gov/pubmed/37731627
http://dx.doi.org/10.1016/j.jtocrr.2023.100561

Ejemplares similares